Department of Health and Human Services June 12, 2024 – Federal Register Recent Federal Regulation Documents
Results 1 - 13 of 13
Notice of Federal Review of the Alabama Protection and Advocacy System (P&A)
Representatives of the Administration on Disabilities (AoD), Administration for Community Living (ACL), will be conducting a federal review of the Alabama Protection and Advocacy System (P&A), Alabama Disability Advocacy Program (ADAP) on July 22-26, 2024. AoD is soliciting comments from interested parties on your experiences with the program, and strategies employed by the P&A ADAP in meeting the needs of individuals with developmental disabilities and their families in Alabama.
Proposed Information Collection Activity; Office of Community Services Affordable Housing and Supportive Services Demonstration Data Collection (Office of Management and Budget #: 0970-0628)
The Office of Community Services (OCS), Administration for Children and Families (ACF), U.S. Department of Health and Human Services, is requesting an extension of approval for a recently approved information collection: OCS Affordable Housing and Supportive Services Demonstration (Office of Management and Budget (OMB) #: 0970- 0628; Expiration Date: September 30, 2024). This information collection was originally approved for 6 months as an emergency approval. In addition to extending the approval, OCS seeks to update the burden estimates to accommodate an anticipated increase in the number of grant recipients, as well as to collect additional responses to several of the instruments. OCS also seeks to make updates to approved forms.
Development of Public Health Vaccine and Prevention Educational Campaigns Involving Community Health Workers
The U.S. Department of Health and Human Services (HHS) Office of Minority Health (OMH) seeks input on involving community health workers (CHWs) to increase "cultural competency in educational campaigns on public health vaccines and prevention, including but not limited to influenza and COVID-19."
Statement of Organization, Functions, and Delegations of Authority
The Administration for Children and Families (ACF) has realigned the Office of Refugee Resettlement (ORR). This notice makes ORR's Refugee Program and Unaccompanied Children Program the Refugee Program Bureau and the Unaccompanied Children Bureau, respectively; creates the Bureau of Operations; and aligns divisions with the bureau they support.
Implementing Interoperable Systems and Processes for Enhanced Drug Distribution Security Requirements Under the Federal Food, Drug, and Cosmetic Act; Notice; Request for Information and Comments; Reopening of the Comment Period
The Food and Drug Administration (FDA or Agency) is publishing this request for information to better understand the status of trading partners' interoperable systems and processes for enhanced drug distribution security as required by the Food, Drug and Cosmetic Act (FD&C Act). FDA is reopening the comment period for the notice, published in the Federal Register of November 20, 2023, establishing a public docket and requesting information and comments, to allow interested persons additional time to comment.
The Tobacco Products Scientific Advisory Committee; Notice of Meeting; Amendment of Notice
The Food and Drug Administration (FDA or Agency) is announcing an amendment of the notice of meeting of the Tobacco Products Scientific Advisory Committee (TPSAC). This meeting was announced in the Federal Register of May 6, 2024. The amendment is being made to reflect a change in the ADDRESSES portion of the document and to reflect a change in the Procedure portion. There are no other changes.
Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding, Repackaging, and Related Activities Regarding Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection associated with Agency guidance documents pertaining to pharmacies, outsourcing facilities, and other entities with regard to human drug compounding, repackaging, and related activities.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
